Medicine and Dentistry
Pediatrics
71%
Airway Smooth Muscle
69%
Airway Smooth Muscle Cell
62%
Clinical Trial
40%
Asthma
36%
Cell Proliferation
27%
Extubation
27%
Airway Resistance
21%
Phosphatase
20%
Cytoskeleton
20%
Pediatrics Patient
17%
Smooth Muscle
16%
Lung
16%
Actin
16%
Intensive Care
16%
Continuous Positive Airway Pressure
15%
Y-27632
14%
Breathing
14%
Silo-Filler's Disease
13%
Thermal Burn
13%
Methacholine
13%
Oxygen Consumption
13%
Cystic Fibrosis
13%
Clonidine
13%
Isotopes of Calcium
13%
Pulmonary Hemorrhage
13%
Lung Mechanics
13%
Ventilator Weaning
13%
Airway Obstruction
13%
Muscle Contractility
13%
Focal Adhesion
13%
Cell Strain
13%
Disease Severity
13%
Messenger RNA
13%
Morphine
13%
Withdrawal Syndrome
13%
Health Outcomes
11%
Cell Membrane
9%
Bleeding
9%
Rho Kinase Inhibitor
8%
Smooth Muscle Contractility
8%
Child Health
7%
Environmental Influence
7%
Placebo
7%
Cytometry
6%
Binding Assay
6%
Particular Matter 2.5
6%
Fine Particulate Matter
6%
Clostridium Botulinum Type A
6%
Myosin Light Chain Kinase
6%
Immunology and Microbiology
Airway
100%
Airway Smooth Muscle Cell
84%
Smooth Muscle
67%
Mechanical Stress
31%
Actin
29%
Asthma
27%
Cell Proliferation
27%
Lower Respiratory Tract
27%
Myosin
25%
Drug Megadose
18%
Arm
17%
Muscle Contractility
17%
Rigidity
14%
Lymphocyte Count
13%
Actin Filament
13%
CD4
13%
Cytoskeleton
13%
Focal Adhesion
13%
Microfilament
13%
Blood Transfusion
13%
T Cell
13%
Dynamics
13%
Allele
13%
Leporidae
13%
Terbutaline
13%
Glucocorticoid
13%
Tidal Volume
13%
Pharmacokinetics
13%
Asthmatic State
13%
Endothelin
13%
Muscle
10%
Cell Membrane
9%
Lung Function
8%
Smooth Muscle Contractility
8%
Stress Fiber
7%
Clostridium Botulinum Type A
6%
CD3 Antigen
6%
Patient Coding
6%
Body Weight
6%
Agonist
6%
Blood Pressure
5%
Transmission Electron Microscopy
5%
Protein Content
5%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
73%
Actin
33%
Prospective Study
27%
Clinical Trial
27%
Terbutaline
27%
Pharmacokinetics
27%
Phosphatase
20%
Burn
18%
Lower Respiratory Tract Infection
18%
4 (1 Aminoethyl) N (4 Pyridyl)cyclohexanecarboxamide
15%
Cohort Study
15%
Myosin Light Chain
14%
Tolerability
13%
Lung Hemorrhage
13%
Withdrawal Syndrome
13%
Clonidine
13%
Phenobarbital
13%
Paxillin
13%
Airway Obstruction
13%
Green Fluorescent Protein
13%
Metronidazole
13%
Asthmatic State
13%
Respiratory Tract Infection
13%
Morphine
13%
Heat Shock Protein 27
13%
Bleeding
9%
Talin
9%
Contractile Protein
8%
Rho Kinase Inhibitor
8%
Placebo
7%
Lysophosphatidic Acid
6%
Isoprenaline
6%
RhoA Guanine Nucleotide Binding Protein
6%
Myosin Light Chain Kinase
6%
Muscle Rigidity
6%
Bronchiolitis
6%
Controlled Clinical Trial
6%
Clostridium Botulinum Type A
6%
Chimeric Protein
6%
Lung Dysplasia
5%
Respiratory Failure
5%
Health Disparity
5%
